Prelude Capital Management, LLC Becton Dickinson & CO Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $73,597 - $80,497	-327 Reduced 20.0%	1,308 $305,000
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $381,690 - $405,038	1,635 New	1,635 $404,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $47,559 - $246,262	932 New	932 $208,000
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $675,613 - $750,041	-2,773 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $638,011 - $695,856	2,773 New	2,773 $697,000
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $1.08 Million - $1.19 Million	-4,639 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $1.08 Million - $1.18 Million	4,639 New	4,639 $1.13 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $292,897 - $324,182	-1,262 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $23,967 - $26,561	-108 Reduced 7.88%	1,262 $316,000
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $295,604 - $379,161	1,370 New	1,370 $319,000
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $94,107 - $106,194	-398 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $91,770 - $101,919	398 New	398 $101,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.